U.S. markets closed
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • Dow 30

    33,761.05
    +424.38 (+1.27%)
     
  • Nasdaq

    13,047.19
    +267.27 (+2.09%)
     
  • Russell 2000

    2,016.62
    +41.36 (+2.09%)
     
  • Crude Oil

    91.88
    -2.46 (-2.61%)
     
  • Gold

    1,818.90
    +11.70 (+0.65%)
     
  • Silver

    20.83
    +0.49 (+2.39%)
     
  • EUR/USD

    1.0257
    -0.0068 (-0.66%)
     
  • 10-Yr Bond

    2.8490
    -0.0390 (-1.35%)
     
  • GBP/USD

    1.2139
    -0.0064 (-0.52%)
     
  • USD/JPY

    133.4800
    +0.4810 (+0.36%)
     
  • BTC-USD

    24,511.37
    +54.15 (+0.22%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

Read How Analysts Reacted To Cintas' Q4 Results

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • RBC Capital analyst Ashish Sabadra lowered the price target on Cintas Corp (NASDAQ: CTAS) to $450 (an upside of 16%) from $475, citing elevated macroeconomic uncertainty. Sabadra maintained the Outperform rating on the shares.

  • The analyst stated that CTAS' 4Q22 results beat expectations and provided strong FY23 revenue guidance. He believes revenues are more resilient than the prior downturn, namely the Global Financial Crisis in 2008.

  • Sabadra believes that cross-selling opportunities, robust pricing, share gains, improved retention, and large vertical opportunities such as healthcare/education/government bode well for growth.

  • RelatedCintas Q4 Earnings Top Estimates

  • The analyst sees fuel headwinds abating, lower than his estimate of 38bps, where these headwinds could lessen if oil continues to decline.

  • Low net leverage (<2x) provides significant buyback and M&A opportunities, Sabadra added.

  • Morgan Stanley analyst Toni Kaplan raised the price target on Cintas to $362 (a downside of 6.5%) from $357 while maintaining the Equal-Weight rating on the shares.

  • Price Action: CTAS shares are trading higher by 0.10% at $387.52 on the last check Friday.

Latest Ratings for CTAS

Date

Firm

Action

From

To

Jan 2022

Morgan Stanley

Maintains

Equal-Weight

Dec 2021

Argus Research

Maintains

Buy

Dec 2021

Morgan Stanley

Maintains

Equal-Weight

View More Analyst Ratings for CTAS

View the Latest Analyst Ratings

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.